Tango Therapeutics, Inc. (TNGX)

Tango Therapeutics Revenue

Tango Therapeutics had revenue of $3.18M in the quarter ending June 30, 2025, a decrease of -83.99%. This brings the company's revenue in the last twelve months to $24.30M, down -42.85% year-over-year. In the year 2024, Tango Therapeutics had annual revenue of $42.07M with 15.17% growth.

• Revenue (ttm): $24.30M
• Revenue Growth: -42.85%
• P/S Ratio: 31.19
• Revenue / Employee: $156,748
• Employees: 155
• Market Cap: 765.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	42.07M	5.54M	15.17%
Dec 31, 2023	36.53M	11.67M	46.93%
Dec 31, 2022	24.86M	-12.18M	-32.89%
Dec 31, 2021	37.04M	29.39M	383.83%
Dec 31, 2020	7.66M	-16.99M	-68.94%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.